URINARY NEUROPILIN-1 (NRP-1) AS A PROGNOSTIC MARKER FOR NEPHRITIS AND LUPUS NEPHRITIS

This invention refers to the methods for predicting the progress of nephritis and lupus nephritis in an individual. This invention also refers to the methods for evaluating the development of nephritis, particularly lupus nephritis, in an individual, and his/her response to a treatment.

Saved in:
Bibliographic Details
Main Authors ORDIROS Josep, TORRES SALIDO Maria Teresa, HOTTER CORRIPIO Georgina, VINAS MUNOZ Jose Luis, SOLA MARTINEZ Ana Maria, CORTES HERNANDEZ Josefina
Format Patent
LanguageEnglish
Published 25.08.2016
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:This invention refers to the methods for predicting the progress of nephritis and lupus nephritis in an individual. This invention also refers to the methods for evaluating the development of nephritis, particularly lupus nephritis, in an individual, and his/her response to a treatment.
Bibliography:Application Number: US201414903716